NCT05701176View on ClinicalTrials.gov

A Clinical Imaging Study of the Changes in [18F]F-AraG Uptake Following Anti-PD-1 Therapy in Non-small Cell Lung Cancer

NARecruitingINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

November 3, 2022

Primary Completion Date

January 31, 2027

Study Completion Date

January 31, 2028

Conditions
Advanced Stage Non-small Cell Lung Cancer
Interventions
DIAGNOSTIC_TEST

[18F]F-AraG PET scan

\[18F\]F-AraG PET scans are performed to assess the accumulation of activated T-cells in the tumour and healthy tissue.

Trial Locations (1)

1081 HV

RECRUITING

Amsterdam UMC, location VU University Medical Center, Amsterdam

Sponsors

Collaborators (1)

Boehringer Ingelheim
All Listed Sponsors
collaborator

Boehringer Ingelheim

INDUSTRY

lead

Amsterdam UMC, location VUmc

OTHER

NCT05701176 - A Clinical Imaging Study of the Changes in [18F]F-AraG Uptake Following Anti-PD-1 Therapy in Non-small Cell Lung Cancer | Biotech Hunter | Biotech Hunter